Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 9;102(23):e33911. doi: 10.1097/MD.0000000000033911

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Molecular pathological markers show significant differential expression between LTSP and thecoma. (A and B) Immunohistochemical staining of the luteinized cells is (A) diffusely positive for Catenin beta-1 (β-Catenin) and the thecoma cells are (B) negative with β-Catenin. (C–F) CD99 antigen (CD99) and Wilms tumor protein (WT1) are (C, E) weak in the luteinized cells but (D, F) strongly positive in the thecoma cells. (G) Statistical analysis of the 3 markers. Data are expressed as mean ± SD. n = 9 to 10 sections per marker (G, LTSP); n = 81 to 87 sections per marker (G, Thecoma). *P < .05, ***P < .001 (t test). Scale bar, 500 μm. AOD = average optical density, LTSP = luteinized thecoma associated with sclerosing peritonitis.